mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.2 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |